The week at Retraction Watch featured a first in transparency from Canada, and the second retraction for a fan of a conspiracy theory. Here’s what was happening elsewhere: Read the rest of this entry »
We previously reported on three retractions — two by the Journal of Controlled Release (JCR) — of papers co-authored by Hossein Hosseinkhani, who is currently based at the National Taiwan University of Science and Technology in Taipei. Now, the JCR is pulling four more studies that list Hosseinkhani as a co-author.
We’ve previously reported on six retractions of papers co-authored by Yoshihiro Sato, who is based at Mitate Hospital in Japan, including one in JAMA. Retractions stemmed from the use of “honorary” co-authors, as well as concerns over the data. One paper seemed to be the victim of “extensive self-plagiarism.”
Sato, who is the first and corresponding author of all ten retractions (including the letter), accepted full responsibility of the newly retracted publications, noting that none of the co-authors took part in any misconduct.
In November 2015, MedChemComm issued an expression of concern (EOC) for the same paper. According to the EOC, the author of the paper, Yong Yang, flagged the paper to the journal, citing problems with authorship and portions of text overlap, which Yang attributed to an editing company.
The editor-in-chief of the journal told us Yang’s institution — China Medical University — carried out an investigation into the case at the journal’s request.
We’ve also found a 2015 retraction for Yang, after he published a paper without the okay of his previous institution in Texas.
A Parkinson’s researcher has earned his fourth retraction after receiving a two-year suspended sentence for fraud.
The sentence for Bruce Murdoch, issued on March 31, 2016, came following an investigation by his former employer, the University of Queensland (UQ) in Australia, into 92 papers. Murdoch entered guilty pleas for 17 fraud-related charges, which resulted in the retraction of three papers co-authored by Murdoch and Caroline Barwood, another former UQ Parkinson’s researcher who faced fraud charges (and was granted bail in 2014).
Now, a fourth retraction has appeared for Murdoch in Brain Injury, this time for duplication and failing to obtain consent from his co-authors.
Over several months, the authors proposed a series of corrections to the 2014 study. However, the journal Annals of the Rheumatic Diseases (ARD) decided that there were “unresolved concerns” about the reliability of the data, and decided to retract the paper entirely, despite the authors’ objections.
A former postdoctoral researcher at the Mount Sinai School of Medicine in New York has received a five-year funding ban after an investigation concluded that they had falsified data underlying more than 50 images.
According to a report released today by the Office of Research Integrity (ORI), Zhiyu Li falsified Read the rest of this entry »
If you’ve searched recently for retracted articles in PubMed — the U.S. National Library of Medicine’s database of scientific abstracts — you may have noticed something new.
In fact, you may have had trouble ignoring it, which is sort of the point. “It” is a large salmon banner that looks something like this: Read the rest of this entry »
An autism researcher is retracting a paper she shared with the director of a New York institute, following a misconduct investigation.
In 2011, suspicions raised by peer reviewers triggered the investigation into several papers by Xiaohong Li at the Institute for Basic Research in Developmental Disabilities (IBR) in New York. The probe concluded in 2013 that there was no evidence of misconduct, but the committee recommended the institute review all relevant papers. This additional review led to the latest retraction, the result of problems with figures which “underpin the conclusions of the study.”
Here’s the retraction notice for “Alteration of astrocytes and Wnt/beta-catenin signaling in the frontalcortex of autistic subjects,” published in the Journal of Neuroinflammation:
The Canadian Institutes of Health Research (CIHR) has banned a bone researcher for life following a finding of misconduct. And in a first, the agency has named her, in their report out today.
The case of Sophie Jamal may be familiar to Retraction Watch readers, as we covered it in October of last year following reporting by The Toronto Star. JAMA retracted a 2011 study by Jamal and colleagues in December, as we reported, and she resigned her positions at Women’s College Hospital (WCH) and the University of Toronto.
Jamal, according to the an investigating committee at WCH: Read the rest of this entry »